Evidence map›Paper›PMID 39131077›Full record

ArticleClinical kidney journal2024

The validity of pathology codes for biopsy-confirmed kidney disease in the Danish National Patobank.

Marie Møller, Iain Bressendorff, Rikke Borg, Hans Dieperink, Jon W Gregersen, Helle Hansen, Kristine Hommel, Mads Hornum, Per Ivarsen, Karina H Jensen and 9 more

Abstract read
In one paragraph

Article in Clinical kidney journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Marie MøllerDepartment of Nephrology, Copenhagen University Hospital Herlev-Gentofte, Herlev, Denmark.ORCID https://orcid.org/0000-0002-1248-1740
Iain BressendorffDepartment of Nephrology, Copenhagen University Hospital Herlev-Gentofte, Herlev, Denmark.
Rikke BorgDepartment of Medicine, Zealand University Hospital, Roskilde, Denmark.
Hans DieperinkDepartment of Nephrology, Odense University Hospital, Odense, Denmark.
Jon W GregersenDepartment of Nephrology, Aalborg University Hospital, Aalborg, Denmark.
Helle HansenDepartment of Nephrology, University Hospital of Southern Denmark, Esbjerg, Denmark.ORCID https://orcid.org/0000-0001-6430-7595
Kristine HommelDepartment of Medicine, Holbaek Hospital, Holbaek, Denmark.
Mads HornumDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-0123-4007
Per IvarsenDepartment of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Karina H JensenDepartment of Medicine, Zealand University Hospital, Roskilde, Denmark.ORCID https://orcid.org/0000-0002-4424-8708
Morten B JørgensenDepartment of Nephrology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Tilde KristensenDepartment of Internal Medicine, Viborg Regional Hospital, Viborg, Denmark.
Dorrit KrustrupDepartment of Pathology, Copenhagen University Hospital Herlev-Gentofte, Herlev, Denmark.
Frank H MoseUniversity Clinic in Nephrology and Hypertension, University of Aarhus and Gødstrup Hospital, Herning, Denmark.ORCID https://orcid.org/0000-0002-5830-5814
Peter RossingDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-1531-4294
Kjeld E OtteDepartment of Medicine, Lillebaelt Hospital Kolding, Kolding, Denmark.
Frederik PerssonDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.ORCID https://orcid.org/0000-0001-6242-6638
Kristine D SchandorffDepartment of Endocrinology and Nephrology, Nordsjællands Hospital, Hillerød, Denmark.
Ditte HansenDepartment of Nephrology, Copenhagen University Hospital Herlev-Gentofte, Herlev, Denmark.ORCID https://orcid.org/0000-0003-4929-7901

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study validates the application of Systematized Nomenclature of Medicine second edition (SNOMED II) codes used to describe medical kidney biopsies in Denmark in encoded form, aiming to support robust epidemiological research on the causes, treatments and prognosis of kidney diseases. Methods: Kidney biopsy reports from 1 January 1998 to 31 December 2018 were randomly extracted from the Danish National Patobank, using SNOMED codes. A 5% sample was selected, and nephrologists assessed the corresponding medical records, assigning each case the applied clinical diagnoses. Sensitivity, specificity, positive predictive values (PPV), negative predictive values and Cohen's kappa coefficient for the retrieved SNOMED codes were calculated. Results: A total of 613 kidney biopsies were included. The primary clinical disease groups were glomerular disease ( Conclusions: SNOMED codes have a high PPV for glomerular diseases, diabetic nephropathy and systemic diseases affecting the kidney, in which they could be applied for future epidemiological research.

Indexed as

Danish National Patient Registrykidney biopsynephrologySNOMED codesvalidation

Identifiers

PMID39131077
PMCPMC11316393

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.